Skip to main content

Table 1 Target regions within Conserved Domain RT_rtv

From: An RNAi in silico approach to find an optimal shRNA cocktail against HIV-1

Region No.

Residue Position

(wild type)

Residue

(wild type)

Function annotation

HXB2 coordinates

Mutation in RT2 and prevalence3

Evaluated Region in MA4

1

24, 25

W,P

DBS

2619-2622

-

2610 - 2630

2

60

V

-

2727

I(14)

2700 - 2760

 

61

F

AS

2730

-

 
 

62

A

-

2733

V(14)

 
 

64

K

-

2736

R(1.9)

 
 

65

K

dBS

2742

R(2.1)

 
 

67

D

-

2748

N(38), G(2.5)

 

3

72

R

dBS

2763

-

2750 -2800

 

74-76, 78, 81

L,V,D,R,N

DBS-AS

2769-2790

-

 

4

89

E

DBS-AS

2814

-

2800 - 2840

 

90

V

-

2828

I(3.3)

 
 

91,92,94

Q,L,I

DBS-AS

2820-2829

-

 

5

100-103

L,K,K,K

NNBS

2847-2856

-

2835 - 2870

6

110-115

D,V,G,D,A,Y

dBS-AS

2877-2892

-

2865 - 2905

7

151

Q

dBS-AS

3000

M(3.4)

2985-3020

 

152,154,157

G,K,P

DBS-AS

3003-3018

-

 

8

178

I

-

3081

M(7.5), L(6.4)

3070-3130

 

179

V

NNBS

3084

I(7.9), D(1.3)

 
 

181

Y

-

3090

C(14)

 
 

183

Y

NNBS-DBS-AS

3096

-

 
 

184

M

variable

3099

V(50), I(1.4)

 
 

185

D

dBS-AS

3102

-

 
 

186

D

AS

3105

-

 
 

188

Y

NNBS

3111

L(3.5)

 
 

190

G

NNBS

3117

-

 

9

227

F

NNBS

3228

L(1.6)

3210-3255

 

228

L

-

3231

H(12), R(4.2)

 
 

230

M

DBS-AS

3237

L(1.8)

 
 

231

G

DBS-AS

3240

-

 
  1. 1Positions according to the HXB2 reference genome numbering system (coordinate map)
  2. 2RT drug resistance mutations prevalence was calculated from 17,167 sequences exposed to either of these drug types (HIV Drug Resistance Database)
  3. 3Mutation prevalence (percent) data are available at the HIV Drug Resistance Database
  4. 4MSA: multiple alignment
  5. In bold, residues directly involved in enzyme activity
  6. DBS, DNA binding site
  7. dBS, dNTP binding site
  8. NNBS, non-nucleoside reverse transcriptase inhibitor binding site
  9. AS, active site